News & Updates

High iron level ups risk of noncommunicable disease in adolescents

20 Mar 2023

A recent study in India has found a significant association between high serum ferritin (SF) and noncommunicable disease (NCD) in adolescents. Additionally, such interaction is dependent on wealth and coexisting prediabetes.

High iron level ups risk of noncommunicable disease in adolescents

20 Mar 2023

1 in 6 adolescent girls in Hong Kong iron-deficient

18 Mar 2023 by

A cross-sectional study of 523 adolescents finds a 17.1 percent and 10.9 percent prevalence of iron deficiency (ID) and ID with anaemia (IDA), respectively, among girls in Hong Kong.

1 in 6 adolescent girls in Hong Kong iron-deficient

18 Mar 2023

New therapies needed for CNS coccidioidomycosis in children: study

17 Mar 2023

A recent study has provided further evidence on the incidence of central nervous system (CNS) coccidioidomycosis, which is a rare and potentially dangerous complication of disseminated coccidioidomycosis. Many patients present with relatively low compliment fixation (CF) titer, and hydrocephalus often occurs.

New therapies needed for CNS coccidioidomycosis in children: study

17 Mar 2023

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

16 Mar 2023

The duration of antiviral prescribing has become much shorter with the introduction of the Biofire Filmarray meningitis/encephalitis (M/E) panel, a study has shown. However, its influence on antibiotic prescribing or health services in a paediatric hospital is minimal.

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

16 Mar 2023

Ultra-short, high-dose primaquine helps prevent P vivax infection in paediatric malaria

16 Mar 2023

For children with uncomplicated malaria, early treatment with an ultra-short course of high-dose primaquine is noninferior to delayed treatment at preventing Plasmodium vivax infection, according to a study.

Ultra-short, high-dose primaquine helps prevent P vivax infection in paediatric malaria

16 Mar 2023

Original New Drug Application Approvals by US FDA (01-15 March 2023)

16 Mar 2023

New drug applications approved by US FDA as of 01-15 March 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 March 2023)

16 Mar 2023

Concurrent use of methylphenidate, selective serotonin reuptake inhibitor generally safe

15 Mar 2023

Using methylphenidate and a selective serotonin reuptake inhibitor (SSRI) together does not appear to pose any significant risk, with both agents having been shown to be safe in adolescent patients with attention deficit-hyperactivity disorder (ADHD) and depression, according to a new-user cohort study.

Concurrent use of methylphenidate, selective serotonin reuptake inhibitor generally safe

15 Mar 2023

Small for gestational age tied to reduced lung function in middle age

14 Mar 2023 by

Being born small for gestational age (SGA) appears to contribute to a reduced lung function during middle age, reveals a study.

Small for gestational age tied to reduced lung function in middle age

14 Mar 2023

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

11 Mar 2023

Children born to mothers who were taking pravastatin during the second and third trimesters of pregnancy do not appear to have any identifiable long-term neurodevelopmental safety risks, as reported in a study.

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

11 Mar 2023

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

09 Mar 2023

Prenatal exposure to plastic-derived chemicals, such as bisphenol A (BPA) and phthalates, tends to increase the risk of asthma, particularly in males, a study has shown.

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

09 Mar 2023

News & Updates

Filter by Specialty:

Specialty:

High iron level ups risk of noncommunicable disease in adolescents

High iron level ups risk of noncommunicable disease in adolescents

1 in 6 adolescent girls in Hong Kong iron-deficient

1 in 6 adolescent girls in Hong Kong iron-deficient

New therapies needed for CNS coccidioidomycosis in children: study

New therapies needed for CNS coccidioidomycosis in children: study

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

Ultra-short, high-dose primaquine helps prevent P vivax infection in paediatric malaria

Ultra-short, high-dose primaquine helps prevent P vivax infection in paediatric malaria

Original New Drug Application Approvals by US FDA (01-15 March 2023)

Original New Drug Application Approvals by US FDA (01-15 March 2023)

Concurrent use of methylphenidate, selective serotonin reuptake inhibitor generally safe

Concurrent use of methylphenidate, selective serotonin reuptake inhibitor generally safe

Small for gestational age tied to reduced lung function in middle age

Small for gestational age tied to reduced lung function in middle age

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

Prenatal exposure to plastic chemicals ups asthma risk in male offspring